{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:11:16Z","timestamp":1772507476417,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf01273155","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T03:16:25Z","timestamp":1111634185000},"page":"581-590","source":"Crossref","is-referenced-by-count":16,"title":["Antiparkinsonian effect of flupirtine in monoamine-depleted rats"],"prefix":"10.1007","volume":"103","author":[{"given":"M.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nolden-Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Purr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pergande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","volume":"249","author":"H Bergman","year":"1990","unstructured":"Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436?1438","journal-title":"Science"},{"key":"CR2","first-page":"787","volume":"73","author":"W Birkmayer","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O (1961) Der L-3,4-Dioxyphenyalanin (-DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73: 787?788","journal-title":"Wien Klin Wochenschr"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1097\/00001756-199412000-00056","volume":"5","author":"F Block","year":"1994","unstructured":"Block F, Pergande G, Schwarz M (1994) Flupirtine protects against ischaemic retinal dysfunction in rats. NeuroReport 5: 2630?2632","journal-title":"NeuroReport"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870060208","volume":"6","author":"JM Brotchie","year":"1991","unstructured":"Brotchie JM, Mitchell IJ, Sambrock MA, Crossman AR (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 6: 133?138","journal-title":"Mov Disord"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01258633","volume":"75","author":"M Carlsson","year":"1989","unstructured":"Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221?226","journal-title":"J Neural Transm"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(87)90738-2","volume":"143","author":"KH Carlsson","year":"1987","unstructured":"Carlsson KH, Jurna I (1987) Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord. Eur J Pharmacol 143: 89?99","journal-title":"Eur J Pharmacol"},{"key":"CR7","first-page":"189","volume-title":"Excitatory amino acids","author":"M Carlsson","year":"1992","unstructured":"Carlsson M, Svensson A, Carlsson A (1992) Interaction between excitatory amino acids, catecholamines and acetylcholine in the basal ganglia. In: Simon RP (ed) Excitatory amino acids. Thieme, New York, pp 189?194"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0306-4522(93)90595-7","volume":"54","author":"TM Engber","year":"1993","unstructured":"Engber TM, Anderson JJ, Boldry RC (1993) N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to Dl and D2 dopamine agonists in rats with unilateral 6-hydroxydopamine lesion. Neuroscience 54: 1051?1061","journal-title":"Neuroscience"},{"key":"CR9","first-page":"89","volume-title":"The scientific basis for the treatment of Parkinson's disease","author":"S Fahn","year":"1992","unstructured":"Fahn S (1992) Adverse effects of levodopa. In: Olanow CW, Lieberman AN (eds) The scientific basis for the treatment of Parkinson's disease. Parthenon, Carnforth, pp 89?112"},{"key":"CR10","first-page":"142","volume":"547","author":"M Filion","year":"1991","unstructured":"Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547: 142?151","journal-title":"Brain Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2165\/00003495-199345040-00007","volume":"45","author":"HA Friedel","year":"1993","unstructured":"Friedel HA, Fitton A (1993) Flupirtine: a review of its pharmacological properties and therapeutic efficacy in pain states. Drugs 45: 548?569","journal-title":"Drugs"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.410350605","volume":"35","author":"JT Greenamyre","year":"1994","unstructured":"Greenamyre JT, Eller RV, Zhang Z, Ovadia A, Kurlan R, Gash DM (1994) Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann Neurol 35: 655?661","journal-title":"Ann Neurol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00498570","volume":"313","author":"U Havemann","year":"1980","unstructured":"Havemann U, Winkler M, Kuschinsky K (1980) Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats. Naunyn Schmiedebergs Arch Pharmacol 313: 139?144","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","volume":"28","author":"T Klockgether","year":"1990","unstructured":"Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats. Ann Neurol 28: 539?546","journal-title":"Ann Neurol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.410340413","volume":"34","author":"T Klockgether","year":"1993","unstructured":"Klockgether T, Turski L (1993) Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann Neurol 34: 585?593","journal-title":"Ann Neurol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02259538","volume":"3","author":"PA L\ufffdschmann","year":"1991","unstructured":"L\ufffdschmann PA, Lange KW, Kunow M, Rettig KJ, J\ufffdhnig P, Honor\ufffd T, Turski L, Wachtel H, Jenner P, Marsden CD (1991) Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-DOPA in models of Parkinson's disease. J Neural Transm [PD-Sect] 3: 203?213","journal-title":"J Neural Transm [PD-Sect]"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(74)90067-3","volume":"26","author":"J Maj","year":"1974","unstructured":"Maj J, Sowinska H, Baran L, Samek J (1974) Pharmacological effect of 1,3-dimethyl-5-amino-adamantane, a new adamantane derivative. Eur J Pharmacol 26: 9?14","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0306-4522(89)90120-6","volume":"32","author":"IJ Mitchell","year":"1989","unstructured":"Mitchell IJ, Clarke CE, Boyce S (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32: 213?226","journal-title":"Neuroscience"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/bja\/55.5.429","volume":"55","author":"R Moore","year":"1983","unstructured":"Moore R, Bullingham RES, Simpson S, O'Sullivan G, Evans PJD, McQuay J (1983) Comparison of flupirtine maleate and dihydrocodeine in patients following surgery. Br J Anaesth 55: 429?432","journal-title":"Br J Anaesth"},{"key":"CR20","first-page":"402","volume":"260","author":"M Morelli","year":"1992","unstructured":"Morelli M, Fenu S, Pinna A, Di Chiara G (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behaviour in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260: 402?408","journal-title":"J Pharmacol Exp Ther"},{"key":"CR21","first-page":"909","volume":"40","author":"B Nickel","year":"1990","unstructured":"Nickel B, Jakovlev V, Szelenyi I (1990) Effects of flupirtine, some analgesics and of muscle relaxants on sceletal muscle tone in conscious rats. Arzneimittelforschung\/Drug Res 40: 909?911","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(94)91510-5","volume":"667","author":"NN Osborne","year":"1994","unstructured":"Osborne NN, Pergande G, Block F, Schwarz M (1994) Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rat retina. Brain Res 667: 291?294","journal-title":"Brain Res"},{"key":"CR23","first-page":"274","volume":"37","author":"NN Osborne","year":"1996","unstructured":"Osborne NN, Schwarz M, Pergande G (1996) Protection of rabbit retina from ischaemic injury by flupirtine. Invest Ophthalmol Vis Sci 37: 274?280","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0922-4106(94)90006-X","volume":"288","author":"S Perovic","year":"1994","unstructured":"Perovic S, Schleger C, Pergande G, Iskric I, Ushijima H, Rytik P, M\ufffdller WEG (1994) The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur J Pharmacol 288: 27?33","journal-title":"Eur J Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0165-6147(93)90005-5","volume":"14","author":"MA Rogawski","year":"1993","unstructured":"Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325?331","journal-title":"Trends Pharmacol Sci"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0014-2999(95)00570-6","volume":"294","author":"K Rupalla","year":"1995","unstructured":"Rupalla K, Cao W, Krieglstein J (1995) Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. Eur J Pharmacol 294: 469?473","journal-title":"Eur J Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(89)90007-5","volume":"32","author":"WJ Schmidt","year":"1989","unstructured":"Schmidt WJ, Bubser M (1989) Anticataleptic effects of N-methyl-D-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32: 621?623","journal-title":"Pharmacol Biochem Behav"},{"key":"CR28","first-page":"65","volume":"38","author":"WJ Schmidt","year":"1992","unstructured":"Schmidt WJ, Bubser M, Hauber W (1992) Behavioural pharmacology of glutamate in the basal ganglia. J Neural Transm 38 [Suppl]: 65?89","journal-title":"J Neural Transm"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.50.1.66","volume":"50","author":"E Scholz","year":"1986","unstructured":"Scholz E, Diener HC, Noth J, Friedemann H, Dichgans J, Bacher M (1986) Medium and long latency EMG responses in leg muscles: Parkinson's disease. J Neurol Neurosurg Psychiatry 50: 66?70","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/00001756-199410000-00036","volume":"5","author":"M Schwarz","year":"1994","unstructured":"Schwarz M, Block F, Pergande G (1994) N-methyl-D-aspartate (NMDA) mediated muscle relaxant action of flupirtine in rats. NeuroReport 5: 1981?1984","journal-title":"NeuroReport"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(95)00043-K","volume":"276","author":"M Schwarz","year":"1995","unstructured":"Schwarz M, Schmitt T, Pergande G, Block F (1995) N-methyl-D-aspartate and ?-2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 276: 247?255","journal-title":"Eur J Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/jnnp.34.5.616","volume":"34","author":"BT Shahani","year":"1971","unstructured":"Shahani BT, Young RR (1971) Human flexor reflexes. J Neurol Neurosurg Psychiatry 34: 616?627","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR33","first-page":"1","volume":"223","author":"G Steg","year":"1964","unstructured":"Steg G (1964) Efferent muscle innervation and rigidity. Acta Physiol Scand [Suppl] 223: 1?53","journal-title":"Acta Physiol Scand [Suppl]"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0924-980X(95)00049-Q","volume":"97","author":"D Timmann","year":"1995","unstructured":"Timmann D, Plummer C, Schwarz M, Diener HC (1995) Influence of flupirtine on human lower limb reflexes. Electroencephalogr Clin Neurophysiol 97: 184?188","journal-title":"Electroencephalogr Clin Neurophysiol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01273155\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:14:35Z","timestamp":1556633675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01273155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF01273155"],"URL":"https:\/\/doi.org\/10.1007\/bf01273155","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}